Concord Biotech Limited

Web: concordbiotech.com NSE: CONCORDBIO BSE: 543960 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

1429 19(-1%)

Volume

70k as on 03, Sep

Open

1,953

High

1,980

Low

1,934

1,448

VWAP

1,449

52 Week High

1,730

52 Week Low

987

Viand Research Rating

Quality Score

44/100

Growth Score

19/100

Valuation Score

50/100

Momentum Score

50/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

14,948

No. of Shares

10.5

P/E

64.82

P/B

13.39

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

20.67

ROCE

Profit Growth

Listing Date

18-Aug-23

Promoter Holding

44.08%

FII Holding

7.53%

DII Holding

9.37%

Price Chart

Price Performance

1 Week2%

1 Month3%

3 Months21%

6 Months21%

1 Year13%

YTD8%

Moving Average

5 Day SMA1,461

10 Day SMA1,499

20 Day SMA1,490

30 Day SMA1,441

50 Day SMA1,385

61 Day SMA1,377

80 Day SMA1,323

200 Day SMA1,267

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,530	1,459	1,511	1,529
Resistance 2	1,511	1,454	1,492	1,511
Resistance 1	1,478	1,450	1,479	1,477
Pivot Point	1,460	1,445	1,460	1,459
Support 1	1,426	1,440	1,440	1,425
Support 2	1,408	1,435	1,427	1,407
Support 3	1,374	1,431	1,408	1,373

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Promoters	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%	(0.01) 44.08%
FIIs	(-0.31) 7.53%	(0.21) 7.79%	(-0.41) 7.58%	(-1.11) 8.03%	(-0.31) 9.10%	(1.01) 9.35%	(0.21) 8.33%	(1.01) 8.10%	(0.61) 7.11%	(-0.51) 6.49%	(-0.31) 7.00%	(0.01) 7.30%
DIIs	(0.11) 9.37%	(-0.41) 9.22%	(0.01) 9.58%	(0.71) 9.55%	(-0.31) 8.85%	(-0.51) 9.16%	(-0.21) 9.65%	(-0.51) 9.89%	(1.91) 10.35%	(0.01) 8.41%	(0.31) 8.40%	(0.01) 8.12%
Public	39.04%	38.90%	38.75%	38.32%	37.94%	37.41%	37.93%	37.95%	38.46%	41.03%	40.52%	40.50%
No. of Shareholders	83,325	82,249	81,815	82,650	82,045	81,219	82,004	84,298	80,737	83,296	87,486	100,927

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022
Sales	257	326	278	247	204	430	244	310	216	319	241	262	195	273	241	159	181
Sales Growth % (YoY)	26.2%	-24.2%	13.7%	-20.4%	-5.5%	34.8%	1.4%	18.2%	10.8%	17%	0%	65.1%	7.6%	-	-	-	-
Sales Growth % (QoQ)	-21.2%	17.3%	12.6%	21.1%	-52.6%	76.2%	-21.3%	43.5%	-32.3%	32.4%	-8%	34.4%	-28.6%	13.3%	51.6%	-12.2%	-
Expenses	175	208	179	159	143	241	146	176	135	187	135	147	123	146	131	121	116
Operating Profit	82	118	98	88	61	189	98	134	81	132	106	116	72	127	110	37	65
OPM %	32	36	35	36	30	44	40	43	38	41	44	44	37	47	46	24	36
Other Income	14	15	7	16	15	9	17	10	12	11	11	8	13	12	9	6	14
Interest	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1
Depreciation	18	20	19	18	18	15	13	13	13	14	14	13	13	14	14	13	14
Profit before tax	78	114	86	86	59	184	101	130	80	129	103	110	71	124	105	30	64
Tax %	26	22	26	26	25	24	25	27	25	26	25	26	23	26	26	26	23
Net Profit	58	88	64	63	44	140	76	96	60	95	78	81	54	91	77	22	49
Net Profit Growth % (QoQ)	-34.1%	37.5%	1.6%	43.2%	-68.6%	84.2%	-20.8%	60%	-36.8%	21.8%	-3.7%	50%	-40.7%	18.2%	250%	-55.1%	-
Net Profit Growth % (YoY)	31.8%	-37.1%	-15.8%	-34.4%	-26.7%	47.4%	-2.6%	18.5%	11.1%	4.4%	1.3%	268.2%	10.2%	-	-	-	-
TTM Net Profit	273	259	311	323	356	372	327	329	314	308	304	303	244	239	148	71	0
EPS in Rs	5.59	8.49	6.16	6.08	4.21	13.42	7.26	9.15	5.7	9.08	7.41	7.74	5.21	8.75	7.4	2.1	51.79

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Sales	1055	1200	1017	853	713	616	512
Sales Growth %	-12.1%	18%	19.2%	19.7%	15.7%	20.3%	-
Expenses	687	694	585	509	443	289	308
Operating Profit	368	506	432	344	270	327	205
OPM %	35	42	42	40	38	53	40
Other Income	52	44	37	37	23	14	32
Interest	1	1	3	5	6	1	1
Depreciation	74	54	54	54	50	28	21
Profit before tax	345	495	413	322	238	313	214
Tax %	25	25	25	25	26	25	21
Net Profit	259	372	308	240	175	235	169
Net Profit Growth %	-30.4%	20.8%	28.3%	37.1%	-25.5%	39.1%	-
EPS in Rs	24.94	35.52	29.45	22.95	183.93	247.44	177.81
Dividend Payout %	30	25	30	30	3	0	22

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Cash from Operating Activity	267	245	265	246	207	167	155
Cash from Investing Activity	-143	-160	-155	-158	-112	-195	-114
Cash from Financing Activity	-113	-99	-99	-85	-100	31	-43
Net Cash Flow	11	-14	12	3	-4	3	-1

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020
Equity Capital	10	10	10	10	10	10	10	10	10
Reserves	2007	1817	1802	1580	1516	1280	1094	990	761
Borrowings	2	2	3	3	10	32	62	86	52
Other Liabilities	212	194	219	171	164	192	147	97	118
Total Liabilities	2232	2023	2034	1764	1701	1514	1313	1183	941
Fixed Assets	789	795	795	558	575	593	573	546	240
CWIP	79	74	51	249	211	173	74	18	141
Investments	491	353	335	276	246	137	74	141	199
Other Assets	873	802	854	682	668	611	592	477	361
Total Assets	2232	2023	2034	1764	1701	1514	1313	1183	941

Delivery

Delivery Data: CONCORDBIO

#	Date	1238 30% 1615	Value (Cr)	Q/T 11	Del 43	Del 18
1	4-Sep	1417	8	8	52	4
2	3-Sep	1448	10	8	48	5
3	2-Sep	1445	13	9	48	6
4	1-Sep	1484	29	10	41	12
5	31-Aug	1446	28	8	54	15
6	28-Aug	1481	13	8	45	6
7	27-Aug	1482	28	8	49	14
8	26-Aug	1542	9	6	49	4
9	25-Aug	1548	8	8	47	4
10	24-Aug	1539	22	11	40	9
11	21-Aug	1571	15	10	34	5
12	20-Aug	1577	23	8	34	8
13	19-Aug	1588	31	12	43	13
14	18-Aug	1566	77	14	34	26
15	17-Aug	1515	90	13	37	33
16	14-Aug	1451	17	9	56	9
17	13-Aug	1454	16	9	48	8
18	12-Aug	1445	13	10	45	6
19	11-Aug	1429	40	12	37	14
20	10-Aug	1419	51	10	29	15
21	7-Aug	1365	9	11	47	4
22	6-Aug	1375	16	9	48	7
23	5-Aug	1385	14	9	51	7
24	4-Aug	1420	35	10	45	16
25	3-Aug	1415	57	14	42	24
26	31-Jul	1421	84	15	40	34
27	30-Jul	1330	22	13	50	11
28	29-Jul	1330	24	9	52	12
29	28-Jul	1256	4	7	54	2
30	27-Jul	1256	10	10	53	5
31	24-Jul	1248	6	6	45	3
32	23-Jul	1268	4	7	49	2
33	22-Jul	1284	12	10	52	6
34	21-Jul	1329	9	8	48	4
35	20-Jul	1335	10	8	48	5
36	17-Jul	1343	12	8	44	5
37	16-Jul	1346	9	8	42	4
38	15-Jul	1339	12	10	42	5
39	14-Jul	1328	14	10	48	7
40	13-Jul	1352	20	12	51	10
41	10-Jul	1305	26	11	53	14
42	9-Jul	1305	16	10	45	7
43	8-Jul	1260	20	11	34	7
44	7-Jul	1273	12	8	48	6
45	6-Jul	1284	12	10	53	6
46	3-Jul	1275	15	16	33	5
47	2-Jul	1286	8	10	46	4
48	1-Jul	1286	15	11	56	8
49	30-Jun	1280	11	8	53	6
50	29-Jun	1262	26	10	48	12

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	14,948c	226c	1.49
03-Sep	15,174c	240c	1.55
01-Sep	15,413c	82c	0.53
31-Aug	15,332c	298c	1.91
27-Aug	15,630c	685c	4.20
26-Aug	16,315c	240c	1.49
25-Aug	16,075c	143c	0.88
24-Aug	16,219c	80c	0.49
21-Aug	16,298c	336c	2.02
19-Aug	16,634c	178c	1.08
18-Aug	16,456c	513c	3.22
17-Aug	15,944c	844c	5.59
14-Aug	15,099c	68c	0.45
13-Aug	15,031c	86c	0.57
12-Aug	15,117c	117c	0.77
11-Aug	15,234c	313c	2.10
10-Aug	14,921c	641c	4.49
07-Aug	14,280c	172c	1.19
06-Aug	14,452c	162c	1.11
05-Aug	14,614c	346c	2.31
04-Aug	14,960c	154c	1.04
03-Aug	14,806c	48c	0.32
31-Jul	14,855c	856c	6.11
30-Jul	13,999c	454c	3.35
29-Jul	13,545c	415c	3.16
28-Jul	13,129c	115c	0.87
27-Jul	13,244c	0	0

Stock Checklist

Price is above from 52 week high low average: 59%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 90 fund scheme(s) across 24 fund house(s) as of Aug26 · Total value ₹1,267 Cr · 49 increasing / 2 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
DSP Mutual Fund	8	1.11%	+0.09%	519.6
SBI Mutual Fund	6	1.34%	-0.01%	212.5
Edelweiss Mutual Fund	4	1.14%	+0.29%	161.6
quant Mutual Fund	2	9.66%	+9.66%	76.7
Tata Mutual Fund	2	1.91%	+1.91%	58.9
Invesco Mutual Fund	4	0.41%	+0.04%	50.6
Nippon India Mutual Fund	6	0.19%	+0.02%	48.8
Baroda BNP Paribas Mutual Fund	4	1.56%	+1.02%	44.1
ITI Mutual Fund	2	1.13%	+0.03%	33.2
Canara Robeco Mutual Fund	2	0.66%	+0.19%	22.3
Groww Mutual Fund	8	0.56%	+0.83%	14.4
Motilal Oswal Mutual Fund	6	0.08%	+0.02%	7
Bandhan Mutual Fund	8	0.56%	-	5.6
HDFC Mutual Fund	6	0.13%	+0.02%	3.9
ICICI Prudential Mutual Fund	4	0.20%	+0.02%	3.3
Taurus Mutual Fund	2	0.41%	+0.41%	2.9
Jio BlackRock Mutual Fund	1	0.22%	+0.03%	0.9
Kotak Mahindra Mutual Fund	2	0.21%	+0.02%	0.3
Axis Mutual Fund	2	0.02%	-	0.2
UTI Mutual Fund	2	0.08%	+0.01%	0.1
Navi Mutual Fund	4	0.05%	+0.01%	0
Angel One Mutual Fund	2	0.02%	-	0
Mirae Asset Mutual Fund	2	0.02%	-	0
Zerodha Mutual Fund	1	0.10%	-	0

Concord Biotech Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements